Literature DB >> 3342719

Plasma CCK levels in patients with pancreatic insufficiency.

T Bozkurt1, G Adler, I Koop, H Koop, W Türmer, R Arnold.   

Abstract

After stimulation with a Lundh test meal, plasma concentrations of cholecystokinin (CCK) and pancreatic polypeptide (PP) and output of pancreatic enzymes were measured in 33 patients with exocrine pancreatic insufficiency and 26 healthy subjects. Patients with impairment of pancreatic function were subdivided into those with moderate and severe insufficiency. Plasma CCK and PP were measured by radioimmunoassay. Fasting plasma CCK in patients with pancreatic insufficiency (5.8 +/- 1.1 pmol/liter) did not differ significantly from controls (4.2 +/- 0.6 pmol/liter). After endogenous stimulation with a Lundh meal, plasma CCK increased in both groups without significant differences over 2 hr. Basal and stimulated plasma levels of pancreatic polypeptide (PP) were markedly decreased only in patients with severe pancreatic insufficiency. Our results demonstrate that basal and meal-stimulated CCK levels in patients with pancreatic insufficiency do not differ from controls. Furthermore the extent of functional impairment of the exocrine pancreas did not influence basal and postprandial CCK release.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342719     DOI: 10.1007/bf01535749

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Effects of intestinal amylase and trypsin on pancreatic secretion in the pig.

Authors:  I Ihse; P Lilja
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

2.  Plasma cholecystokinin levels in patients with chronic pancreatitis.

Authors:  A Schafmayer; H D Becker; M Werner; U R Fölsch; W Creutzfeldt
Journal:  Digestion       Date:  1985       Impact factor: 3.216

3.  Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enteropancreatic reflex.

Authors:  C Owyang; D May; D S Louie
Journal:  Gastroenterology       Date:  1986-09       Impact factor: 22.682

4.  Adult cystic fibrosis: postprandial response of gut regulatory peptides.

Authors:  J M Allen; A R Penketh; T E Adrian; Y C Lee; D L Sarson; M E Hodson; J C Batten; S R Bloom
Journal:  Gastroenterology       Date:  1983-12       Impact factor: 22.682

5.  Evaluation of serum pancreatic polypeptide estimations following hormonal stimulation for the diagnosis of exocrine pancreatic insufficiency.

Authors:  W Cichy; P G Lankisch; R Arnold; W Creutzfeldt
Journal:  Digestion       Date:  1984       Impact factor: 3.216

6.  Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin.

Authors:  C Owyang; D S Louie; D Tatum
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

7.  Correlation between exocrine pancreatic secretion and serum concentration of human pancreatic polypeptide in chronic pancreatitis.

Authors:  B N Andersen; C Hagen; H C Klein; F Stadil; H Worning
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

8.  Plasma cholecystokinin concentrations in patients with pancreatic insufficiency measured by sequence-specific radioimmunoassays.

Authors:  J B Jansen; W P Hopman; C B Lamers
Journal:  Dig Dis Sci       Date:  1984-12       Impact factor: 3.199

9.  Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol.

Authors:  R A Liddle; I D Goldfine; J A Williams
Journal:  Gastroenterology       Date:  1984-09       Impact factor: 22.682

10.  Low plasma cholecystokinin response after ingestion of a test meal in patients with chronic pancreatitis.

Authors:  A Funakoshi; I Nakano; H Shinozaki; H Ibayashi; K Tateishi; T Hamaoka
Journal:  Am J Gastroenterol       Date:  1985-12       Impact factor: 10.864

View more
  8 in total

Review 1.  Perspectives of CCK antagonists in pancreatic research and clinical use. Part I.

Authors:  L C Rovati
Journal:  Int J Pancreatol       Date:  1991-04

2.  Effect of oral protease inhibitor administration on gallbladder motility in patients with mild chronic pancreatitis.

Authors:  M Sugiyama; Y Atomi; N Wada; A Kuroda; T Muto
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

3.  No negative feedback regulation between plasma CCK levels and luminal tryptic activities in patients with pancreatic insufficiency.

Authors:  T Nakamura; K Takebe; K Kudoh; M Ishii; K Imamura; H Kikuchi; F Kasai; Y Tandoh; N Yamada; Y Arai
Journal:  Int J Pancreatol       Date:  1995-02

4.  Postprandial cholecystokinin response in patients with chronic pancreatitis in treatment with oral substitutive pancreatic enzymes.

Authors:  M C Garcés; J Gómez-Cerezo; R Codoceo; C Grande; J Barbado; J J Vázquez
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

5.  Reversible gall bladder dysfunction in severe pancreatic insufficiency.

Authors:  A A Masclee; J B Jansen; F H Corstens; C B Lamers
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

6.  Pancreatic polypeptide secretion in patients with chronic pancreatitis and after pancreatic surgery.

Authors:  E H Eddes; M Verkijk; H A Gielkens; I Biemond; W Bemelman; C B Lamers; A A Masclee
Journal:  Int J Pancreatol       Date:  2001

7.  Enzyme replacement therapy for pancreatic insufficiency: present and future.

Authors:  Aaron Fieker; Jessica Philpott; Martine Armand
Journal:  Clin Exp Gastroenterol       Date:  2011-05-04

8.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.